Skip to main content

Ariadna Boloix Amenós

I am a postdoctoral researcher in the group of Childhood Cancer and Blood Disorders. Specifically, I am working on project based on the development and implementation of RNA-based therapies in clinical practice for the treatment of pediatric solid tumors.

Institutions of which they are part

Postdoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
Ariadna Boloix Amenós
I graduated in Pharmacy at the University of Barcelona and next year I studied a master's degree in Biomedicine. In 2015 I started my PhD thesis in collaboration between the Childhood Cancer and Blood Disorders group of VHIR and the Nanomol group of ICMAB-CSIC. Since 2019 when I defended the thesis, I continued working in the preclinical development of a nanomedicine based on the use of lipidic nanoparticles conjugated to microRNAs for the treatment of neuroblastoma as well as other diseases that can be treated with RNA-based therapies. The results of this research are patented (WO2020229469) and are currently pending review for publication in the scientific journal Small.
The nucleic acid administration platform developed in the group has generated the interest of different national or International research groups with which we collaborated or are collaborating.
So far, my purpose has been to advance the levels of technological readiness (TRL) of microRNA-based nanomedicine, which has been carried out while participating in entrepreneurship and innovation programs (Seed Knowledge Grants Program 2018; Bcn Activa Pre-acceleration Program and Ignite Health Program organized by Biocat).
Finally, to complement my training in relevant clinical preclinical studies and improve my knowledge of technology transfer, I began a postgraduate specialization in quality management (UOC).

Projects

Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders

IP: Lucas Moreno Martín-Retortillo
Collaborators: Luís Gros Subias, Raquel Andreu Vilarroig, Andrea Vilaplana Blanes, Pablo Velasco Puyó, Laura Murillo Sanjuán , Nora Diéguez Martínez, Maria Isabel Benitez Carabante, Aroa Soriano Fernández, Guillem Pons Barcons, Jose Miguel Lizcano De Vega, Maria Cristina Díaz de Heredia Rubio, María de los Ángeles Rodríguez Sánchez, Maria Luz Uria Oficialdegui , Maria Jose Pérez García, Miguel Segura Ginard, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, M Mar Mañu Pereira, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Lorena Valero Arrese, Raquel Anta Peña, Thaïs Murciano Carrillo, Constantino Sábado Álvarez, Anna Llort Sales, Elisabet Megías Roda, Raquel Hladun Alvaro, Ariadna Boloix Amenós, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Carlota Aguilera Ordoñez, Adria Molero Valenzuela, Júlia Sansa Girona, Gabriela Guillén Burrieza, Laura Alonso Garcia , Victoria Gutierrez Valle, Idoia Bolinaga Ayala, Josep Roma Castanyer, Sergio Espinosa Gil, Gabriel Osvaldo Gallo , Elena Andretta , Roberta Antonelli , Claire Diot , Amira Idrizovic
Funding agency: AGAUR
Funding: 60000
Reference: 2021 SGR 00638
Duration: 01/01/2022 - 31/12/2024

NEW NANOTOOLS FOR THE TREATMENT OF METASTATIC NEUROBLASTOMA

IP: Miguel Segura Ginard
Collaborators: Soledad Gallego Melcón, NEW NANOTOOLS FOR THE TREATMENT OF METASTATIC NEUROBLASTOMA , Ariadna Boloix Amenós, Roberta Antonelli
Funding agency: Instituto de Salud Carlos III
Funding: 208120
Reference: PI20/00530
Duration: 01/01/2021 - 31/12/2023

Quatsomes as a novel nanomaterial platform for nucleic acids delivery

IP: Miguel Segura Ginard
Collaborators: Soledad Gallego Melcón, Aroa Soriano Fernández, Ariadna Boloix Amenós, Lucas Moreno Martín-Retortillo, Roberta Antonelli
Funding agency: Instituto de Salud Carlos III
Funding: 83600
Reference: DTS20/00018
Duration: 01/01/2021 - 31/12/2022

Investigació translacional en càncer infantil (GRE)

IP: Josep Sánchez de Toledo Codina
Collaborators: Soledad Gallego Melcón, Aroa Soriano Fernández, Maria Cristina Díaz de Heredia Rubio, Miguel Segura Ginard, Anna Llort Sales, Raquel Hladun Alvaro, Ariadna Boloix Amenós, Laura Alonso Garcia , Josep Roma Castanyer
Funding agency: AGAUR
Funding: 30000
Reference: 2014 SGR 660
Duration: 01/01/2014 - 31/12/2016

Related news

Thanks to the donation, the Childhood Cancer and Blood Disorders group at VHIR is doing research to explore the use of liquid biopsy for the prediction of the evolution of patients with this rare disease.

Dr. Lucas Moreno is the first author of the international work that presents a series of considerations for early phase studies with the aim of accelerating the arrival of new therapies to patients with childhood cancer.

El 20% dels pacients en els quals s’havia trobat alguna predisposició genètica van ser diagnosticats amb algun tipus de tumor i van poder iniciar el tractament de manera precoç.

Related professionals

Laura Sararols Ramsay

Laura Sararols Ramsay

Read more
Mª Teresa Pastor Amorós

Mª Teresa Pastor Amorós

Cardiovascular Diseases
Read more
Joan Sanchez de Toledo Sancho

Joan Sanchez de Toledo Sancho

Main researcher
Read more
Patricia García Ortega

Patricia García Ortega

Research technician
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.